Moxidectin steady state prior to inoculation protects cats from subsequent, repeated infection with Dirofilaria immitis

Particle and Fibre Toxicology

Byron L Blagburn³  Chris Basel¹  Lindsay A Starkey²  Jeff Gruntmeir²  Kaylynn Gruntmeir²  Anne W Barrett²  Keith L Bailey⁴  Jennifer E Thomas²  Joe A Hostetler¹  Susan E Little² 

[1] Bayer HealthCare, Animal Health, Shawnee, KS, USA;Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, USA;Department of Veterinary Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA;Oklahoma Animal Disease Diagnostic Laboratory, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, USA

关键词: Steady state;    Moxidectin;    Heartworm;    Dirofilaria immitis;    Cat;   

Others  :  1146803
DOI  :  10.1186/s13071-015-0710-z

 received in 2014-11-13, accepted in 2015-02-03,  发布年份 2015

【 摘 要 】

Background

Infection of cats with Dirofilaria immitis causes seroconversion on antibody tests and pulmonary pathology, often without subsequent development of adult heartworms. Consistent administration of topical 10% imidacloprid-1% moxidectin has been shown to result in sustained plasma levels of moxidectin in cats after three to five treatments, a pharmacokinetic behavior known as “steady state”.

Methods

To evaluate the ability of moxidectin at “steady state” to protect cats from subsequent infection with D. immitis, cats (n = 10) were treated with the labeled dose of topical 10% imidacloprid-1% moxidectin for four monthly treatments. Each cat was inoculated with 25 third-stage larvae of D. immitis 7, 14, 21, and 28 days after the last treatment; non-treated cats (n = 9) were inoculated on the same days, serving as infection controls. Blood samples were collected from each cat from 1 month prior to treatment until 7 months after the final inoculation and tested for antibody to, and antigen and microfilaria of, D. immitis.

Results

Measurement of serum levels of moxidectin confirmed steady state in treated cats. Cats treated with topical 10% imidacloprid-1% moxidectin prior to trickle inoculation of D. immitis L3 larvae throughout the 28 day post-treatment period remained negative on antibody and antigen tests throughout the study and did not develop gross or histologic lesions characteristic of heartworm infection. A majority of non-treated cats tested antibody positive by 3–4 months post infection (6/9) and, after heat treatment, tested antigen positive by 6–7 months post-infection (5/9). Histologic lesions characteristic of D. immitis infection, including intimal and medial thickening of the pulmonary artery, were present in every cat with D. immitis antibodies (6/6), although adult D. immitis were confirmed in only 5/6 antibody-positive cats at necropsy. Microfilariae were not detected at any time.

Conclusions

Taken together, these data indicate that prior treatment with 10% imidacloprid-1% moxidectin protected cats from subsequent infection with D. immitis for 28 days, preventing both formation of a detectable antibody response and development of pulmonary lesions by either immature stages of D. immitis or young adult heartworms.

【 授权许可】

   
2015 Little et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Lee AC, Atkins CE. Understanding feline heartworm infection: disease, diagnosis, and treatment. Top Companion Anim Med. 2010; 25:224-230.
• [2]Ryan WG, Newcomb KM. Prevalence of Feline Heartworm Disease: A Global Review. Proceedings of the American Heartworm Symposium ’95. American Heartworm Society, Batavia, IL, USA; 1995.
• [3]Lorentzen L, Caola AE. Incidence of positive heartworm antibody and antigen tests at IDEXX Laboratories: trends and potential impact on feline heartworm awareness and prevention. Vet Parasitol. 2008; 158:183-190.
• [4]Miller MW, Atkins CE, Stemme K, Robertson-Plouch C, Guerrero J. Prevalence of exposure to Dirofilaria immitis in cats in multiple areas of the United States. Vet Ther. 2000; 1:169-175.
• [5]Browne LE, Carter TD, Levy JK, Snyder PS, Johnson CM. Pulmonary arterial disease in cats seropositive for Dirofilaria immitis but lacking adult heartworms in the heart and lungs. Am J Vet Res. 2005; 66:1544-1549.
• [6]Prichard R, Ménez C, Lespine A. Moxidectin and the avermectins: consanguinity but not identity. Int J Parasitol Drugs Drug Resist. 2012; 2:134-153.
• [7]Arther RG, Charles S, Ciszewski DK, Davis WL, Settje TS. Imidacloprid/moxidectin topical solution for the prevention of heartworm disease and the treatment and control of flea and intestinal nematodes of cats. Vet Parasitol. 2005; 133:219-225.
• [8]Jacobs DE, Arakawa A, Courtney CH, Gemmell MA, McCall JW, Myers GH et al.. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating the efficacy of anthelmintics for dogs and cats. Vet Parasitol. 1994; 52:179-202.
• [9]Taweethavonsawat P, Chungpivat S, Watanapongchati S, Traub RJ, Schaper R. Efficacy of a spot on combination containing imidacloprid 10% and moxidectin 1% against Ancylostoma ceylanicum in cats. Vet Parasitol. 2012; 190:289-293.
• [10]McCall JW, Lindemann BA, Porter CA, OttoG F. Prophylactic Activity of Avermectins Against Experimentally Induced Dirofilaria immitisinfections in Dogs. In: Proceedings of the Heartworm Symposium 1980. Veterinary Medicine Publishing Co, Edwardsville, KS; 1980: p.126-130.
• [11]Genchi C, Venco L, Genchi M. Guideline for the laboratory diagnosis of canine and feline Dirofilaria infections. Mappe Parassitologiche. 2007; 8:137-144.
• [12]Turba ME, Zambon E, Zannoni A, Russo S, Gentilini F. Detection of Wolbachia DNA in blood for diagnosing filaria-associated syndromes in cats. J Clin Microbiol. 2012; 50:2624-30.
• [13]Sokal RR, Rohlf FJ. Biometry. 3rd ed. W. H. Freeman and Co., New York; 1997.
• [14]Little SE, Raymond MR, Thomas JE, Gruntmeir J, Hostetler JA, Meinkoth JH et al.. Heat treatment prior to testing allows detection of antigen of Dirofilaria immitis in feline serum. Parasit Vectors. 2014; 7:1. BioMed Central Full Text
• [15]Blagburn BL, Dillon AR, Arther RG, Butler JM, Newton JC. Comparative efficacy of four commercially available heartworm preventive products against the MP3 laboratory strain of Dirofilaria immitis. Vet Parasitol. 2011; 176:189-194.
• [16]McCracken MD, Patton S. Pulmonary arterial changes in feline dirofilariasis. Vet Pathol. 1993; 30:64-9.
• [17]Maia FC, McCall JW VA, Peixoto CA, Supakorndej P, Supakorndej N, Alves LC. Structural and ultrastructural changes in the lungs of cats Felis catus (Linnaeus, 1758) experimentally infected with D. immitis (Leidy, 1856). Vet Parasitol. 2011; 176:304-12.
• [18]Rawlings CA, Farrell RL, Mahood RM. Morphologic changes in the lungs of cats experimentally infected with Dirofilaria immitis. Response to aspirin. J Vet Intern Med. 1990; 4:292-300.
• [19]Genchi C, Venco L, Ferrari N, Mortarino M, Genchi M. Feline heartworm (Dirofilaria immitis) infection: a statistical elaboration of the duration of the infection and life expectancy in asymptomatic cats. Vet Parasitol. 2008; 158:177-82.
• [20]McCall JW, Guerrero J, Supakorndej P. Evaluation of the accuracy of heartworm antigen and antibody tests for cats. In: Recent Advances in Heartworm Disease Symposium ’98. Seward RL, editor. American Heartworm Society, Batavia, IL; 1998: p.127-134.
• [21]Nelson CT. Feline heartworm infections: diagnosis and management. Compend Contin Educ Pract Vet. 2008; 30:393-400.
• [22]Weil GJ, Malane MS, Powers KG, Blair LS. Monoclonal antibodies to parasite antigens found in the serum of Dirofilaria immitis-infected dogs. J Immunol. 1985; 134:1185-1191.
• [23]Donoghue AR, Piché CA, Radecki SV, Schaad LE, Frank GR. Effect of Prophylaxis on Heartworm Antibody Levels in Cats Receiving Trickle Experimental Infections of Dirofilaria Immitis. The American Heartworm Society: State of the Heartworm Symposium ‘98. 1998.33.
• [24]Donaghue AR, Piche CA, Radeki SV, Scahhad LE, Venco L, Frank GR. The Effect of Preventive on Anti-Dirofilaria immitis Antibodies in Cats Receiving Experimental Infection with D. immitis . 1999.
• [25]Blagburn BL, Dillon AR: Feline heartworm disease – solving the puzzle. Vet Med. 2007;Suppl:7–14.
• [26]Dillon AR, Blagburn BL, Tillson DM, Brawner WR, Welles B, Johnson C et al.. Immature Heartworm Infection Produces Pulmonary Parenchymal, Airway, And Vascular Disease In Cats. Proceedings of the 2007 Triennial Symposium of the American Heartworm Society. 2007.
• [27]Dillon AR, Tillson DM, Wooldridge A, Cattley R, Hathcock J, Brawner B, et al. Effect of pre-cardiac and adult stages of Dirofilaria immitis in pulmonary disease of cats: CBC, bronchial lavage cytology, serology, radiographs, CT images, bronchial reactivity, and histopathology. Vet Parasitol. 2014. in press.